Poland· PL-100253011
Vinpocetine Espefa Forte
A vinpocetine product containing vinpocetinum, registered in Poland by Chemiczno-Farmaceutyczna Spółdzielnia Pracy ESPEFA. The same ATC class is registered in 3 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Vinpocetine is registered in 3 of 19 countries.
Countries holding a registration under ATC N06BX18 (vinpocetine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 3 of them publish a price we can compare per daily dose
Vinpocetine · ATC N06BX18
3 / 19 countries
- Czechiaprice
- Polandprice
- Spainprice
The record
At a glance
URPL (Poland)- Active substance
- Vinpocetinum
- Manufacturer
- Chemiczno-Farmaceutyczna Spółdzielnia Pracy ESPEFA
- Country
- Poland (PL)
- ATC code
- N06BX18
- ATC class
- Vinpocetine
- Defined daily dose
- 15 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909990894857
- gtin05909991024352
- gtin05909991728489
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vinpocetine in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCAVINTON FORTEGedeon Richter Romania S.A., Targu-Mures
- SpainVINPOCETINA COVEX 10 MG COMPRIMIDOSCovex S.A.
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Bulgaria · Vinpocetine Covex, Винпекс
- Czechia · Cavinton, Cavinton Forte
- Spain · Vinpocetina Covex
- Hungary · Cavinton, Cavinton Forte
- Lithuania · Cavinton, Cavinton Forte
- Latvia · Cavinton, Cavinton Forte
- Portugal · Cavinton, Cerbiotiv
- Romania · Cavinton, Cavinton Forte
- Slovenia · Vinpocetin Covex, Vinpocetine Covex
- Slovakia · Cavinton, Cavinton Forte
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ae741a04-ea2e-49c7-b24d-529d3efc2b3e GET /v1/drugs/ae741a04-ea2e-49c7-b24d-529d3efc2b3e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "10 mg",
"packaging": "05909990894857 ¦ Rp ¦ 68710\n30 tabl.\n05909991024352 ¦ Rp ¦ 79292\n90 tabl.\n05909991728489 ¦ Rp ¦ 143098\n180 tabl.",
"substance": "Vinpocetinum 10 mg",
"common_name": "Vinpocetinum",
"pl_product_id": "100253011",
"pozwolenie_nr": "18583",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about vinpocetine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.